Atherosclerotic Risk Factors in Children with Celiac Disease Gastroenterol Res Pract. 2020 Mar 27;2020:6138243. doi: 10.1155/2020/6138243.eCollection 2020. Anna Rybak 1, Aldona Wierzbicka 2, Piotr Socha 3, Anna Stolarczyk 3, Bozena Cukrowska 4, Lukasz Obrycki 5, Zbigniew Wawer 2, Roman Janas 2, Beata Oralewska 2, Anna Szaflarska-Poplawska 6, Barbara Iwanczak 7, Elzbieta Cyrta-Jarocka 8, Urszula Grzybowska-Chlebowczyk 9, Wojciech Cichy 10, Grazyna Czaja-Bulsa 11, Jerzy Socha 3 |
Author information
Abstract Results: We found significantly lower concentrations of total cholesterol, lipoprotein LDL-C, apolipoproteins A1 and B, as well as hCRP in all children with CD. We showed decreased level (<5 ng/mL) of folic acid among 46% of children treated for >5 years. Moreover, we showed significant decrease of folic acid level already after 1 year of a GFD (12 vs. 5.6 ng/mL; p < 0.001). We also found significant negative correlation of z-score body mass index (BMI) with HDL and APOA1 level (r = -0.33; p = 0.015 and r = -0.28; p = 0.038, respectively) and modest positive correlation of z-score BMI with atherogenic factor of total cholesterol-HDL ratio and LDL-HDL ratio (r = 0.40; p = 0.002 and r = 0.36; p = 0.006, respectively). Analysis of physical activity showed an increase in the insulin levels with inactivity (r = 0.36; p = 0.0025). We also found positive correlation of the sleep duration with the adiponectin level (r = 0.41; p = 0.011). Conclusions: In children with CD treated with a GFD, decreased level of folic acid together with increased BMI, sedentary behavior, and an improper lipid profile may predispose them to atherosclerosis in the long run. This data suggests the need of further studies to determine the need for metabolic cardiovascular risk screening in children with CD. |
© Copyright 2013-2025 GI Health Foundation. All rights reserved.
This site is maintained as an educational resource for US healthcare providers only.
Use of this website is governed by the GIHF terms of use and privacy statement.